Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by GARRETT CULLEN
Infusion Reactions Related to Infliximab Therapy Are Not Usually Associated With Drug Discontinuation
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Fc Receptor IIIb Polymorphism and Use of Glucocorticoids at Baseline Are Associated With Infusion Reactions to Infliximab in Patients With Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Amyloidogenic Determinants Are Usually Not Buried
BMC Structural Biology
Structural Biology
Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy
PLoS ONE
Multidisciplinary
Drug Hypersensitivity Reactions in Children: Are There Factors Associated With Severity?
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Prediction of Relapse After Discontinuation of Infliximab Therapy in Severe Sarcoidosis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Early Discontinuation and Non-Adherence to Adjuvant Hormonal Therapy Are Associated With Increased Mortality in Women With Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Incidence and Management of Infusion Reactions to Infliximab in 186 Italian Patient’s With Rheumatoid Arthritis: The Padua Experience
Reumatismo
Rheumatology
Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Low-Dose Glucocorticoid Therapy Decreases Risk for Treatment-Limiting Infusion Reaction to Infliximab in Patients With Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
